The better growth stock for investors may be Eli Lilly due to Zepbound's success, but if you're looking for a more reasonably priced option, then Novo Nordisk may still be worth adding to your ...

It isn't easy to find steady and reliable dividend payers in the pharmaceutical industry. The key reason is simple: Drug ...

The WisdomTree U.S. Quality Dividend Growth Index underwent its annual rebalance on December 11, 2024, refining its holdings ...

Obesity has emerged as one of the most pressing public health challenges globally, affecting over 650 million adults, ...

If you've been following recent advancements in weight loss injections, chances are you've come across Mounjaro (also known ...

Recent sales of a little-known stock, Madrigal Pharmaceuticals (NASDAQ: MDGL), could bode well for Novo Nordisk A/S (NYSE: ...

Pfizer’s financial challenges are offset by growth potential in oncology and strong dividends. Learn why PFE stock is a "Buy" ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 488.46% and ...

Scholars are hailing the discovery of a fossilized mastodon jaw discovered by a man who spotted two giant teeth while ...